India · Delayed Price · Currency is INR Eiko LifeSciences Company Description
Eiko LifeSciences Limited, together with its subsidiary, manufactures and supplies specialty chemicals, fine chemicals, and active pharmaceutical ingredients in India and internationally.
It offers speciality chemicals and intermediates, such as lasamide, trichloro salicylic acid, chloroacetyl xylidide, and thiodipropionic acid; agrochemical intermediates; and cosmetic emollients, including isopropyl oleate, isopropyl palmitate, methyl myristate, butyl laurate, isopropyl laurate, isopropyl myristate, butyl oleate, methyl myristate, and methyl laurate.
The company also provides APIs comprising topiramate, glcosamine HCL/sodium/potassium, minoxidil sulfate, phenylephrine HCL, tamsulosin, nebivolol, lidocaine, minoxidil, furosemide, flurbiprofen, and meloxicam; and flavor and fragrances consisting of coumarin, dihydrocoumarin, benzyl acetone, methyl anthranilate, anisyl acetone, and benzylidine acetone, as well as phenyl ethyl allyl ether, phenyl propyl alcohol, and phenyl ethyl isoamyl ether.
In addition, it exports its products. The company was formerly known as Narendra Investments (Delhi) Limited and changed its name to Eiko LifeSciences Limited in June 2021.
Eiko LifeSciences Limited was incorporated in 1977 and is based in Thane, India.
| Country | India |
| Founded | 1977 |
| Industry | Industrial Organic Chemicals |
| Employees | 7 |
| CEO | Umesh More |
Contact Details
Address: 604, Centrum Thane, 400 604 India | |
| Phone | 91 90 8266 8855 |
| Website | eikolifesciences.com |
Stock Details
| Ticker Symbol | 540204 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2860 |
Key Executives
| Name | Position |
|---|---|
| Umesh More | Chief Executive Officer |
| Jaid Kojar | Chief Financial Officer |